Read Gene

Read Gene Debt / Assets

The Debt-to-Assets Ratio of Read Gene (RDG.WA) as of Oct 17, 2026 is 0.54. In the previous year, Debt-to-Assets Ratio was 0.54 — a change of 1.04% (higher).

Debt / Assets

0.54

YoY

1.04%

Last updated:

Debt-to-Assets Ratio of Read Gene is 2025 0.54 . Debt-to-Assets Ratio of Read Gene was 2024 0.54 . It decreases by 1.04% higher compared to the previous year.

The Read Gene Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2016
0.01 PLN
Jan 1, 2017
0.02 PLN
Jan 1, 2020
0.29 PLN
Jan 1, 2021
0.32 PLN
Jan 1, 2022
0.45 PLN
Jan 1, 2023
0.50 PLN
Jan 1, 2024
0.54 PLN
Jan 1, 2025
0.54 PLN
The Read Gene Debt / Assets history
YEARDebt / AssetsYoY
0.54+1.04%
0.54+8.41%
0.50+10.16%
0.45+42.80%
0.32+9.03%
0.29+1,089.54%
0.02+66.34%
0.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Read Gene Stock analysis

What does Read Gene do? Read Gene SA is a biotechnology company based in Szczecin, Poland, operating within the Health Care sector. The company went public via an IPO on February 12, 2009, and is listed under the ticker RDG.WA with ISIN PLRADGN00014. Read Gene SA focuses on medical research and testing, particularly in the fields of chemoprevention, clinical trials, and genetic testing. Its services include specialized tests for breast cancer, colon cancer, and prostate cancer, alongside medical consultancy and DNA testing. The company also provides DNA-related supplements. It operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o., and its major shareholder is GEN-PAT-MED Sp. z o.o. The company's headquarters are located in Szczecin, within the West Pomeranian Voivodeship. Read Gene SA's activities are centered on developing technologies aimed at detecting, preventing, and treating malignant tumors. The company's website is https://read-gene.com/. No additional details regarding founding year, specific products, or financial figures are provided in the source material. Read Gene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Read Gene stock

Debt-to-Assets Ratio of Read Gene is 0.54 in 2025.

Debt-to-Assets Ratio of Read Gene changed from 0.54 to 0.54, representing a 1.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Read Gene since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Read Gene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Read Gene

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Read Gene